{"id":21471,"date":"2025-01-14T14:02:45","date_gmt":"2025-01-14T06:02:45","guid":{"rendered":"https:\/\/flcube.com\/?p=21471"},"modified":"2025-01-14T14:02:48","modified_gmt":"2025-01-14T06:02:48","slug":"cbc-groups-r-bridge-healthcare-fund-boosts-mirxes-with-40m-for-cancer-detection-expansion","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=21471","title":{"rendered":"CBC Group&#8217;s R-Bridge Healthcare Fund Boosts Mirxes with $40M for Cancer Detection Expansion"},"content":{"rendered":"\n<p>CBC Group&#8217;s R-Bridge Healthcare Fund has made a significant investment of USD 40 million in Mirxes Pte Ltd., a Singapore-based company at the forefront of miRNA technology. This funding is poised to propel Mirxes&#8217; swift growth and its global outreach in the realm of cancer early detection and precision medicine.<\/p>\n\n\n\n<p><strong>Mirxes&#8217; Leadership in miRNA Testing<\/strong><br>Mirxes stands out as a pioneer in crafting and launching precise, non-invasive, and cost-effective blood-based miRNA tests. Its flagship product, GASTROClear, marks a milestone as the world&#8217;s first and only In Vitro Diagnostics (IVD) product for gastric cancer screening. Since gaining regulatory approval in Singapore in 2019, GASTROClear has redefined standards with an 87.5% sensitivity for detecting stage 1 cancers and a 75% sensitivity for lesions under 1 cm. A recent prospective clinical trial in China, involving 9,472 participants, further underscored GASTROClear&#8217;s safety and efficacy as a groundbreaking screening tool for gastric cancer.<\/p>\n\n\n\n<p><strong>Innovation and Market Expansion<\/strong><br>Backed by an industry-leading portfolio of over 90 patents and applications, Mirxes is relentlessly expanding its miRNA technology platform. The company is currently in the process of developing diagnostic solutions for lung, liver, and colorectal cancer. Mirxes is particularly focused on scaling up its operations in the high-growth Asia Pacific region, encompassing Southeast Asia, China, and Japan, to bring its innovative cancer detection solutions to a broader patient population.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>CBC Group&#8217;s R-Bridge Healthcare Fund has made a significant investment of USD 40 million in&#8230;<\/p>\n","protected":false},"author":1,"featured_media":21473,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10,22],"tags":[811],"class_list":["post-21471","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","category-medical-device","tag-mirxes"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>CBC Group&#039;s R-Bridge Healthcare Fund Boosts Mirxes with $40M for Cancer Detection Expansion - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"CBC Group&#039;s R-Bridge Healthcare Fund has made a significant investment of USD 40 million in Mirxes Pte Ltd., a Singapore-based company at the forefront of miRNA technology. This funding is poised to propel Mirxes&#039; swift growth and its global outreach in the realm of cancer early detection and precision medicine.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=21471\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CBC Group&#039;s R-Bridge Healthcare Fund Boosts Mirxes with $40M for Cancer Detection Expansion\" \/>\n<meta property=\"og:description\" content=\"CBC Group&#039;s R-Bridge Healthcare Fund has made a significant investment of USD 40 million in Mirxes Pte Ltd., a Singapore-based company at the forefront of miRNA technology. This funding is poised to propel Mirxes&#039; swift growth and its global outreach in the realm of cancer early detection and precision medicine.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=21471\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-14T06:02:45+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-01-14T06:02:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/01\/1401.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"720\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=21471#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=21471\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"CBC Group&#8217;s R-Bridge Healthcare Fund Boosts Mirxes with $40M for Cancer Detection Expansion\",\"datePublished\":\"2025-01-14T06:02:45+00:00\",\"dateModified\":\"2025-01-14T06:02:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=21471\"},\"wordCount\":234,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=21471#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/1401.png\",\"keywords\":[\"Mirxes\"],\"articleSection\":[\"Company\",\"Deals\",\"Medical Device\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=21471#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=21471\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=21471\",\"name\":\"CBC Group's R-Bridge Healthcare Fund Boosts Mirxes with $40M for Cancer Detection Expansion - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=21471#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=21471#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/1401.png\",\"datePublished\":\"2025-01-14T06:02:45+00:00\",\"dateModified\":\"2025-01-14T06:02:48+00:00\",\"description\":\"CBC Group's R-Bridge Healthcare Fund has made a significant investment of USD 40 million in Mirxes Pte Ltd., a Singapore-based company at the forefront of miRNA technology. This funding is poised to propel Mirxes' swift growth and its global outreach in the realm of cancer early detection and precision medicine.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=21471#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=21471\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=21471#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/1401.png\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/1401.png\",\"width\":1080,\"height\":720,\"caption\":\"CBC Group's R-Bridge Healthcare Fund Boosts Mirxes with $40M for Cancer Detection Expansion\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=21471#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CBC Group&#8217;s R-Bridge Healthcare Fund Boosts Mirxes with $40M for Cancer Detection Expansion\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"CBC Group's R-Bridge Healthcare Fund Boosts Mirxes with $40M for Cancer Detection Expansion - Insight, China&#039;s Pharmaceutical Industry","description":"CBC Group's R-Bridge Healthcare Fund has made a significant investment of USD 40 million in Mirxes Pte Ltd., a Singapore-based company at the forefront of miRNA technology. This funding is poised to propel Mirxes' swift growth and its global outreach in the realm of cancer early detection and precision medicine.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=21471","og_locale":"en_US","og_type":"article","og_title":"CBC Group's R-Bridge Healthcare Fund Boosts Mirxes with $40M for Cancer Detection Expansion","og_description":"CBC Group's R-Bridge Healthcare Fund has made a significant investment of USD 40 million in Mirxes Pte Ltd., a Singapore-based company at the forefront of miRNA technology. This funding is poised to propel Mirxes' swift growth and its global outreach in the realm of cancer early detection and precision medicine.","og_url":"https:\/\/flcube.com\/?p=21471","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-01-14T06:02:45+00:00","article_modified_time":"2025-01-14T06:02:48+00:00","og_image":[{"width":1080,"height":720,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/01\/1401.png","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=21471#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=21471"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"CBC Group&#8217;s R-Bridge Healthcare Fund Boosts Mirxes with $40M for Cancer Detection Expansion","datePublished":"2025-01-14T06:02:45+00:00","dateModified":"2025-01-14T06:02:48+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=21471"},"wordCount":234,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=21471#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/01\/1401.png","keywords":["Mirxes"],"articleSection":["Company","Deals","Medical Device"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=21471#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=21471","url":"https:\/\/flcube.com\/?p=21471","name":"CBC Group's R-Bridge Healthcare Fund Boosts Mirxes with $40M for Cancer Detection Expansion - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=21471#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=21471#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/01\/1401.png","datePublished":"2025-01-14T06:02:45+00:00","dateModified":"2025-01-14T06:02:48+00:00","description":"CBC Group's R-Bridge Healthcare Fund has made a significant investment of USD 40 million in Mirxes Pte Ltd., a Singapore-based company at the forefront of miRNA technology. This funding is poised to propel Mirxes' swift growth and its global outreach in the realm of cancer early detection and precision medicine.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=21471#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=21471"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=21471#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/01\/1401.png","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/01\/1401.png","width":1080,"height":720,"caption":"CBC Group's R-Bridge Healthcare Fund Boosts Mirxes with $40M for Cancer Detection Expansion"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=21471#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"CBC Group&#8217;s R-Bridge Healthcare Fund Boosts Mirxes with $40M for Cancer Detection Expansion"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/01\/1401.png","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/21471","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=21471"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/21471\/revisions"}],"predecessor-version":[{"id":21474,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/21471\/revisions\/21474"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/21473"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=21471"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=21471"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=21471"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}